Newron Pharmaceuticals SpA (NWRN) — Cash Flow-to-Debt Ratio
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of CHF-1.33 Million could theoretically repay 0% of its total liabilities (CHF51.15 Million) in one year. See Newron Pharmaceuticals SpA (NWRN) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Newron Pharmaceuticals SpA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Newron Pharmaceuticals SpA across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Newron Pharmaceuticals SpA.
Annual Cash Flow-to-Debt Ratio for Newron Pharmaceuticals SpA (2005–2025)
Year-by-year debt coverage analysis for Newron Pharmaceuticals SpA. Check NWRN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | CHF32.56 Million | CHF51.15 Million | ▲ +325.7% |
| 2024 | -0.28x | CHF-17.61 Million | CHF62.45 Million | ▼ -55.1% |
| 2023 | -0.18x | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.09 Million | CHF51.23 Million | ▲ +10.4% |
| 2021 | -0.24x | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.94x | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.09x | CHF-15.95 Million | CHF5.16 Million | ▼ -95.0% |
| 2017 | -1.58x | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.86x | CHF-19.58 Million | CHF6.84 Million | ▼ -61.7% |
| 2015 | -1.77x | CHF-12.86 Million | CHF7.27 Million | ▼ -38.3% |
| 2014 | -1.28x | CHF-10.00 Million | CHF7.81 Million | ▼ -26.1% |
| 2013 | -1.02x | CHF-10.69 Million | CHF10.53 Million | ▼ -396.9% |
| 2012 | 0.34x | CHF5.83 Million | CHF17.04 Million | ▲ +148.3% |
| 2011 | -0.71x | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.76x | CHF-19.13 Million | CHF6.94 Million | ▼ -48.1% |
| 2009 | -1.86x | CHF-23.06 Million | CHF12.39 Million | ▼ -37.5% |
| 2008 | -1.35x | CHF-19.93 Million | CHF14.73 Million | ▼ -26.6% |
| 2007 | -1.07x | CHF-13.87 Million | CHF12.97 Million | ▼ -103.2% |
| 2006 | -0.53x | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.21x | CHF-14.33 Million | CHF6.48 Million | — |